A detailed history of James J. Burns & Company, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, James J. Burns & Company, LLC holds 2,007 shares of LLY stock, worth $1.51 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
2,007
Previous 2,007 -0.0%
Holding current value
$1.51 Million
Previous $1.82 Million 2.15%
% of portfolio
0.32%
Previous 0.36%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$724.87 - $909.04 $5,074 - $6,363
7 Added 0.35%
2,007 $1.82 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $1.05 Million - $1.24 Million
2,000 New
2,000 $1.17 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track James J. Burns & Company, LLC Portfolio

Follow James J. Burns & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James J. Burns & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on James J. Burns & Company, LLC with notifications on news.